February 19, 2014 – Dr. Dzau will continue to serve in his current roles through June 30.
It is with great pride that we share the news that the Institute of Medicine (IOM) has named Victor J. Dzau, MD, its next President. As many of you know, the IOM is the nation’s preeminent advisor on issues relating to biomedical research, medicine, and health. Dr. Dzau will continue to serve in his current roles at Duke through June 30 at which point he will be leaving to succeed current IOM president Harvey V. Fineberg, MD, PhD.
Dr. Dzau has provided exceptional leadership across Duke Medicine in his dual role as Chancellor for Health Affairs and President and Chief Executive Officer for Duke University Health System since assuming these roles nearly 10 years ago. Over this period of time, he has emerged as one of the world’s preeminent academic health leaders and is recognized as one of the leading voices in the need for transformation of the academic health centers and for integrated innovation in healthcare delivery. Under Dr. Dzau’s leadership, Duke Medicine’s reputation as a national and global leader in academic medicine has continued to grow. Duke Medicine has consistently ranked among the top academic health centers in the world, and has been recognized for exceptional patient-centered care, cutting edge basic and clinical research, innovative care delivery, and improving community and global health.
Over the past decade, Dr. Dzau has been responsible for creating the Duke Cancer Institute, Duke Translational Medicine Institute, Duke Institute for Health Innovation, and other entities designed to emphasize synergies between research, education, and clinical care. Most recently, under his leadership, Duke University Health System has undergone a historic system-wide transformation of its clinical information systems to a single state-of-the-art electronic health record that supports Duke’s vision of one patient, one record, and one community wherever the patient receives care. He has also been the driving force in initiating Duke Medicine’s global outreach by establishing the Duke – National University of Singapore Graduate Medical School, playing a leading role in the creation of the Duke Global Health Institute, and co-founding the International Partnership for Innovative Heathcare Delivery.
Dr. Dzau has also taken a progressive approach to faculty development through a number of programs he either created or directly supported, and has also established a number of innovative funding mechanisms to provide research support to graduate students, young research faculty, and others needing funding during this time of constrained research investment by NIH. His initiatives have included Chancellor’s Scholars, Global Health Residency, GME Innovation Fund, CCHAMP (Chancellor’s Clinical Leadership in Academic Medicine Program), a program dedicated to providing learning opportunities for Duke Medicine’s clinical faculty leaders of the future, and the MLPR (Management and Leadership Pathway for Residents) program which provides in-depth experiences in leadership and management for selected residents to train as future physician executives.
And, of course, under his leadership the Duke Medicine campus has been transformed with the addition of the new Duke Cancer Center facility, the Duke Medicine Pavilion, the Trent Semans Center for Health Education, a new Duke University School of Nursing facility, and a Duke Eye Center facility that is currently under construction.
There is much more to say, recognize, and celebrate in regard to Dr. Dzau’s achievements on behalf of Duke Medicine, but there will be many other opportunities to do so in the coming months. However, on behalf of the University, the Board of Trustees, and the Health System Board of Directors, we want to express our profound appreciation for the tireless leadership Dr. Dzau has provided to Duke and the long list of accomplishments he has achieved for the organization.
The leadership of the university and health system is developing a process for managing the transition in executive leadership of the health system, including the search for a new chancellor. In the meantime, we are grateful for your continued service and commitment to Duke.
Richard H. Brodhead, President, Duke University
Thomas Gorrie, Chair, Duke University Health System Board of Directors